Sweet, Sour, Salty and...Fat? Scientists Add a New Basic Taste
The thousands of taste buds on a human tongue each contain as many as 100 taste receptors. The interaction between those receptors and the chemicals in our food determine the taste of that hamburger or salad you’re having for lunch.
Our sense of taste has long been broken into four basic categories — sour, sweet, salty and bitter. A fifth basic taste was added more recently: umami, which means “delicious” in Japanese but refers to a meaty or savory flavor sensation. Now researchers claim there’s a sixth basic taste.
Scientists at Purdue University have published a new study in the journal Chemical Sense that they say provides evidence that chemicals called nonesterified fatty acids (NEFA) — in other words, fat — causes a taste sensation that is different from the other five tastes. The researchers have proposed that the new taste be referred to as “oleogustus.” “Oleo” is the root word for oily or fatty in Latin and “gustus” means taste.
Related: The 11 Worst Fast Food Restaurants in America
The researchers emphasize that they are talking about a taste, not just the creamy mouth feel you get from eating a rich piece of meat or a dish loaded in butter.
The fat that delivers that creamy, smooth feeling is a triglyceride, made up of three different fatty acids, they explain. Oleogustus — a gag-inducing taste on its own, but much more appetizing in combination with other flavors — comes from only one of those fatty acids that breaks off from the larger molecule in the food or as you’re chewing.
This finding has the potential to generate big changes in the food industry. Understanding the taste component of fat can do more than add to our knowledge of how our brain and digestive system interact. It may also help the food industry create more appealing, and potentially healthier, products.
Top Reads from The Fiscal Times:
- Teens Are Having Much Less Sex Than Their Parents Did at That Age
- You’re Richer Than You Think. Really.
- The New Generation of ‘Genuinely Creepy’ Electronic Devices
Tax Refunds Rebound
Smaller refunds in the first few weeks of the current tax season were shaping up to be a political problem for Republicans, but new data from the IRS shows that the value of refund checks has snapped back and is now running 1.3 percent higher than last year. The average refund through February 23 last year was $3,103, while the average refund through February 22 of 2019 was $3,143 – a difference of $40. The chart below from J.P. Morgan shows how refunds performed over the last 3 years.
Number of the Day: $22 Trillion
The total national debt surpassed $22 trillion on Monday. Total public debt outstanding reached $22,012,840,891,685.32, to be exact. That figure is up by more than $1.3 trillion over the past 12 months and by more than $2 trillion since President Trump took office.
Chart of the Week: The Soaring Cost of Insulin
The cost of insulin used to treat Type 1 diabetes nearly doubled between 2012 and 2016, according to an analysis released this week by the Health Care Cost Institute. Researchers found that the average point-of-sale price increased “from $7.80 a day in 2012 to $15 a day in 2016 for someone using an average amount of insulin (60 units per day).” Annual spending per person on insulin rose from $2,864 to $5,705 over the five-year period. And by 2016, insulin costs accounted for nearly a third of all heath care spending for those with Type 1 diabetes (see the chart below), which rose from $12,467 in 2012 to $18,494.
Chart of the Day: Shutdown Hits Like a Hurricane
The partial government shutdown has hit the economy like a hurricane – and not just metaphorically. Analysts at the Committee for a Responsible Federal Budget said Tuesday that the shutdown has now cost the economy about $26 billion, close to the average cost of $27 billion per hurricane calculated by the Congressional Budget Office for storms striking the U.S. between 2000 and 2015. From an economic point of view, it’s basically “a self-imposed natural disaster,” CRFB said.
Chart of the Week: Lowering Medicare Drug Prices
The U.S. could save billions of dollars a year if Medicare were empowered to negotiate drug prices directly with pharmaceutical companies, according to a paper published by JAMA Internal Medicine earlier this week. Researchers compared the prices of the top 50 oral drugs in Medicare Part D to the prices for the same drugs at the Department of Veterans Affairs, which negotiates its own prices and uses a national formulary. They found that Medicare’s total spending was much higher than it would have been with VA pricing.
In 2016, for example, Medicare Part D spent $32.5 billion on the top 50 drugs but would have spent $18 billion if VA prices were in effect – or roughly 45 percent less. And the savings would likely be larger still, Axios’s Bob Herman said, since the study did not consider high-cost injectable drugs such as insulin.
